Stem Cell Research in Texas

Stem Cell Research and News: Texas

Geron Announces Publications Demonstrating Efficacy Of GRN163l

Menlo Park, CA – Sept 6, 2005 – Geron Corporation (Nasdaq: GERN) announced today publications demonstrating efficacy of GRN163L, its pan-cancer telomerase inhibitor drug, in mouse models of human hepatocellular carcinoma and human metastatic lung cancer. The studies confirm and...

Posted in Today's Stem Cell Research on September 9, 2005 06:50 PM

Umbilical Cord Blood Bank Pledges Donation to Alex's Lemonade Stand

Labor on Labor Day Funds Pediatric Cancer Research PHILADELPHIA, Sept. 1 - CorCell, Inc., a national, private umbilical cord blood bank, announced today the promise of a monetary donation to Alex's Lemonade Stand, a foundation dedicated to funding pediatric cancer...

Posted in Today's Stem Cell Research on September 2, 2005 03:13 PM

Is Longevity Vaccine in Our Future?

Now this isn't our usual staple of stem cell research. However, sometimes we come across articles that are in a related field .. and since stem cell research so often includes regenerative medicine and the goal of increasing our lifespan...

Posted in Today's Stem Cell Research on August 26, 2005 12:36 PM

Embryonic-Like Stem Cells Derived From Umbilical Cord Blood

In a big boost for adult stem cell research, researchers at Kingston University and University of Texas have discovered a means of producing embryonic-like cells from umbilical cord blood which may substantially speed up the development of treatments for life-threatening...

Posted in Today's Stem Cell Research on August 19, 2005 12:26 PM

Gradient Guides Nerve Growth Down Spinal Cord

The same family of chemical signals that attracts developing sensory nerves up the spinal cord toward the brain serves to repel motor nerves, sending them in the opposite direction, down the cord and away from the brain, report researchers at...

Posted in Today's Stem Cell Research on August 16, 2005 02:17 PM

Brain Tumors May Originate With Neural Stem Cells

Researchers at University of Texas Southwestern Medical Center in Texas have determined that stem cells in a certain region of the brain may be the source of a particular type of incurable brain tumor and may be implicated in other...

Posted in Today's Stem Cell Research on August 16, 2005 01:38 PM

Statewide Public Cord Blood Bank Operational in San Antonio; The Texas Cord Blood Bank Has Begun Accepting Donations

SAN ANTONIO, Aug. 2, 2005 - The Texas Cord Blood Bank (TCBB), a publicly and privately funded program established to create a public supply of umbilical cord blood, announced today that it has begun collection and storage of the life-saving...

Posted in Today's Stem Cell Research on August 5, 2005 06:28 PM

PharmaFrontiers Plans to Ask SEC for Accelerated Effective Date

THE WOODLANDS, Texas--(BUSINESS WIRE)--Jul 27, 2005 - PharmaFrontiers Corp. (OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, filed a Registration Statement on Form SB-2 with the Securities and Exchange Commission (SEC) July 19, 2005. The SEC...

Posted in Today's Stem Cell Research on July 28, 2005 11:35 PM

U.S. BioDefense Sponsors 1-800-STEM-CELLS.com, a Major Success for New Stem Cell Industry Council Non-Profit

CITY OF INDUSTRY, Calif., July 28, 2005 -- U.S. BioDefense, Inc. (OTCBB:UBDE) announced today that it has recently sponsored the successful launch of 1-800-STEM-CELLS.COM, a major success for the Stem Cell Industry Council, a newly formed IRS approved 501C3 Non-Profit...

Posted in Today's Stem Cell Research on July 28, 2005 10:57 PM

Researchers Find Circulating Stem Cells Play Role in Lung Repair

HOUSTON, TEXAS — (July 27, 2005)— Circulating stem cells play a minor role in repairing lung damage, according to a team of scientists who used male and female chromosomal differences to analyze the repair process in lung transplant patients. Reporting...

Posted in Today's Stem Cell Research on July 28, 2005 10:09 AM

PhereSys Therapeutics Announces Consulting Agreement with Advanced Cell & Gene Therapy, LLC

PhereSys(TM) Therapeutics Corporation ("PhereSys") announced today that it has entered into a comprehensive consulting services agreement with Advanced Cell & Gene Therapy LLC ("ACGT"), Scott R. Burger, MD, Principal. Advanced Cell & Gene Therapy, LLC, located in Chapel Hill, North...

Posted in Today's Stem Cell Research on July 27, 2005 05:53 PM

More Evidence Stem Cells Help Heart Patients

Scientists at the Texas Heart Institute are reporting that they have new evidence showing the effectiveness of treating congestive heart failure with a patient's own stem cells. The researchers performed a postmortem examination of a trial participant who died of...

Posted in Today's Stem Cell Research on July 22, 2005 04:46 PM

PhereSys Therapeutics Corp. Sheet

PhereSys Therapeutics Corp. Articles More PhereSys Therapeutics Corp. Articles Corporate Summary (site quote): PhereSys Therapeutics is a privately held company founded to become the premier therapeutic apheresis and cellular therapies provider in the United States. Therapeutic Apheresis or 'blood...

Posted in Today's Stem Cell Research on June 27, 2005 05:43 PM

New Investment Report Reveals Rapid Growth of Stem Cell Technology Research

Investment into stem cell technology is continuing apace despite public controversy and legal and regulatory barriers, according to a report by Marks & Clerk, one of the world’s leading firms of patent and trade mark attorneys. In its Biotechnology Report...

Posted in Today's Stem Cell Research on June 23, 2005 02:18 PM

California Institute for Regenerative Medicine Press Release: ICOC Appoints Members to Scientific and Medical Research Facilities Working Group

EMERYVILLE, CA – The California Institute for Regenerative Medicine (CIRM) announced the appointment by the Independent Citizens’ Oversight Committee (ICOC) of members to serve on its Scientific and Medical Research Facilities Working Group (Facilities Working Group). The members were recommended...

Posted in Today's Stem Cell Research on June 16, 2005 11:30 AM

Geron Announces Publication Characterizing GRN163L, Its Telomerase Inhibitor Drug Currently in Clinical Development for Cancer

MENLO PARK, Calif.--(BUSINESS WIRE)--June 1, 2005--Geron Corporation (Nasdaq:GERN) announced today the publication of data on cell and animal testing of GRN163L, its telomerase inhibitor anti-cancer drug. The results describe (1) the synthesis and structure of GRN163L, (2) its potency for...

Posted in Today's Stem Cell Research on June 3, 2005 06:48 AM

PharmaFrontiers Adds Three Members to Its Scientific Advisory Board

THE WOODLANDS, Texas May 17, 2005 PharmaFrontiers Corp. (OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, announced today that it has appointed three new members to its scientific advisory board (SAB). The new members are Norman...

Posted in Today's Stem Cell Research on May 17, 2005 01:54 PM

President's Council on Bioethics Report Outlines Human Embryonic Stem Cell Research Alternatives

As expected, the President's Council on Bioethics on Thursday released a report outlining possible ways to move forward with embryonic stem cell research without "upsetting ethical concerns" by describing methods for producing stem cells without destroying human embryos, Reuters...

Posted in Today's Stem Cell Research on May 16, 2005 01:48 AM

U.S. BioDefense To Partner With MD Andersen

U.S. BioDefense (OTCBB:UBDE) announced that it has entered into a definitive agreement with the University of Texas MD Anderson Cancer Center. The company has the priority option to review and license the patent pending technology entitled ``Use of Non-marrow Stem...

Posted in Today's Stem Cell Research on May 13, 2005 04:54 PM

U.S. Biodefense, Inc. New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with U. of Texas

CITY OF INDUSTRY, Calif., May 10, 2005 (PRIMEZONE) -- U.S. BioDefense (OTCBB:UBDE) announced today that it has entered into a definitive agreement with the University of Texas MD Anderson Cancer Center. The company has the priority option to review and...

Posted in Today's Stem Cell Research on May 12, 2005 12:02 PM

Method Of Growing Stem Cells That Do Not Turn Cancerous

Regenetech Inc., a Houston-based, adult-stem-cell company, said today recent scientific studies of adult stem cells expanded with its NASA-created techniques indicate the cells do not turn cancerous. Last week researchers from Spain and Denmark reported in the journal “Cancer Research”...

Posted in Today's Stem Cell Research on May 9, 2005 10:54 AM

Regenetech Announces Adult Stem Cells Safe

OUSTON—Regenetech Inc., a Houston-based, adult-stem-cell company, said today recent scientific studies of adult stem cells expanded with its NASA-created techniques indicate the cells do not turn cancerous. Last week researchers from Spain and Denmark reported in the journal "Cancer Research"...

Posted in Today's Stem Cell Research on May 5, 2005 01:37 PM

PharmaFrontiers Announces Dr. Eliezer Huberman to Chair Scientific Advisory Board

THE WOODLANDS, Texas--(BUSINESS WIRE)--April 26, 2005--PharmaFrontiers Corp. (OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, announced today that Dr. Eliezer Huberman, Ph.D., an authority in the area of adult pluripotent stem cell technology, has agreed to...

Posted in Today's Stem Cell Research on May 1, 2005 11:41 AM

Report Proposes Structure for National Network of Cord Blood Stem Cell Banks

WASHINGTON -- To achieve a more cohesive national system for storing and distributing lifesaving stem cells derived from umbilical cord blood, the U.S. Department of Health and Human Services should establish a new National Cord Blood Policy Board to set...

Posted in Today's Stem Cell Research on April 15, 2005 02:53 PM

PharmaFrontiers Provides Update, Financial Results

THE WOODLANDS, Texas--(BUSINESS WIRE)--April 15, 2005--PharmaFrontiers Corp. (OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, today provides an update on its research programs and future plans. In addition, the Company reports financial results for the 12...

Posted in Today's Stem Cell Research on April 15, 2005 02:34 PM

New Gene Therapy and Stem Cell Technique Using Natural Repair Processes

By artificially initiating a DNA repair process known as homologous recombination, Dr. Matthew Porteus of UT Southwestern, working with scientists from Richmond, Calif.-based Sangamo Biosciences, was able to replace a mutated version of the gene that encodes a portion of...

Posted in Today's Stem Cell Research on April 10, 2005 11:32 PM

MultiCell Appoints Leading Stem Cell Expert to its Scientific Advisory Board

SAN DIEGO--(BUSINESS WIRE)--April 6, 2005--MultiCell Technologies, Inc. (OTCBB:MUCL), a leading supplier of non-tumorigenic immortalized human hepatocytes, announced today that it has appointed Markus Grompe, MD to the newly formed Stem Cell Panel of its Scientific Advisory Board. The Company's Scientific...

Posted in Today's Stem Cell Research on April 6, 2005 06:51 PM

Geron and Exeter Life Sciences Form Joint Venture for Licensing Animal Cloning Technologies

MENLO PARK, Calif. & PHOENIX--(BUSINESS WIRE)--April 6, 2005--Geron Corporation (Nasdaq:GERN) and Exeter Life Sciences, Inc. announced today the formation of stART Licensing, Inc., a new company that will manage and license a broad portfolio of intellectual property rights related to...

Posted in Today's Stem Cell Research on April 6, 2005 02:54 PM

Texas Lawmakers Filing Frightening Proposals Targetting Embryonic Stem Cell Research

While sufferers of chronic and fatal disorders pray scientists will beat the clock to find remedies to their illnesses, two Texas lawmakers are doing their best to stop this promising quest for treatments and cures. Sen. Ken Armbrister, D-Victoria, and...

Posted in Today's Stem Cell Research on March 14, 2005 09:32 AM

Regenerative Medicine Discussion at University of Houston in Texas

Professor Dame Julia Polak, a pioneer in stem cell research and regenerative medicine, will speak at the University of Houston at 4:15 p.m., Tuesday, on March the 8th. The event is open to the public. In the seminar on "Stem...

Posted in Today's Stem Cell Research on March 2, 2005 03:14 AM

Superior Growth and Differentiation of Embryonic Stem Cells on 3-D Bio-Scaffold Reported

Embryonic stem cells grown on three-dimensional biocompatible scaffolds exhibited more efficient differentiation into a variety of hematopoietic progenitor cells, as reported in the February (Volume 11, Number 1-2) issue of Tissue Engineering, a peer-reviewed journal published by Mary Ann Liebert,...

Posted in Today's Stem Cell Research on March 1, 2005 07:25 PM

Cord Blood Bank List

With stem cell research so closely tied to Umbilical Cord Blood, we thought it a good idea to get a somewhat comprehensive list of Cord Blood Banks put together. Additionally, since we have been tracking a many stem cell research...

Posted in Today's Stem Cell Research on February 22, 2005 01:55 PM

Stem Cells' Promise Pits Jobs vs. Values

stem cell research,stem cell,biotech,biotech industry,biotech jobs,embryonic stem cell research,embryonic stem cell,embryo,biotechs,bill banning,stem cells

Posted in Today's Stem Cell Research on February 16, 2005 02:31 PM

Dental Scientists to Present Stem-Cell Briefing on Capitol Hill

The American Association for Dental Research (AADR), the American Dental Association (ADA) and the American Dental Education Association (ADEA) will host a briefing on Capitol Hill, providing some of the latest information on stem cell research by dental scientists. On...

Posted in Today's Stem Cell Research on February 14, 2005 08:49 PM

Lawmaker Pushes Umbilical Cord Donation

The Umbilical Cord Blood Banking Act, introduced Wednesday by Sen. Nancy Rodriguez, would require doctors to inform pregnant women about umbilical cord donation and require hospitals to allow pregnant patients to arrange for such donations....

Posted in Today's Stem Cell Research on February 3, 2005 08:52 PM

Stem Cell Research Debate In Texas

Scientists believe stem cell research could provide promising treatments and cures for everything from diabetes to cancer and heart disease. The question is if and how Texas can help future stem cell research....

Posted in Today's Stem Cell Research on January 27, 2005 01:41 PM

More on U.S. State Level Stem Cell Funding

Current State level developments in the funding of stem cell research is still moving forward at a rapid pace: New York state Sen. David Paterson, a Democrat, introduced legislation last weekend that, if approved by voters, would dedicate $1 billion...

Posted in Today's Stem Cell Research on January 20, 2005 11:56 AM

Today's Stem Cell Research

Stem Cell Research and News: Texas

Stem Cell Categories

Stem Cell Monthly